Tisch MS Research Center of New York Exceeds $300K Crowdfunding Target for FDA-Approved Stem Cell Trial

Please read our press release on the success of the Tisch MSRCNY Phase I Clinical Stem Cell Trial campaign on Indiegogo.com.  To continue to support this important initiative CLICK HERE.

We are truly grateful to everyone who is helping to fund our mission to repair the damage caused by multiple sclerosis.

Indiegogo Goal Reached release.pdf